norethindrone has been researched along with Weight Gain in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbary, F; Berman, JM; Dean, J; Hüttemann, M; Kramer, KJ; Recanati, MA; Wade, S | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA | 1 |
| Berry, KF; Kaser, DJ; Laufer, MR; Missmer, SA | 1 |
| Benhamou, CL; Garnero, P; Jamin, C; Pelissier, C; Roux, C | 1 |
| DICKINSON, JH; SMITH, GG | 1 |
| Shittu, O; Sule, S | 1 |
| Darney, PD; Haider, S | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| Fournet, N; Judd, HL; Surrey, ES; Voigt, B | 1 |
| Bonnet, P; Botella, J; Delansorne, R; Duc, I; Fraboul, F; Paris, J | 1 |
| Lachnit, U; Lehnert, J; Weber-Diehl, F | 1 |
| Anstee, P; Kovacs, GT | 1 |
| el-Hussinie, M; el-Nahal, N; Hassan, EO | 1 |
| Cromie, MA; Garceau, RJ; Kaunitz, AM | 1 |
| Ballagh, SA; Bradshaw, KD; Nichols, M; Stanczyk, FZ; Thorneycroft, IH; Weber, ME | 1 |
| Kaunitz, AM | 1 |
| Albrecht, G; Arboleda, C; Bailon, R; Bassol, S; Bucheli, R; Carneiro de Oliveira, H; Carranza, S; Castañeda, A; Celis, C; Chada, E; Cravioto, MC; de Andrade, ME; de Mello, NR; de Melo, K; Durand, M; Fugarolas, J; Gaona, R; Garza-Flores, J; Gomez, P; Gurucharri, C; Hidalgo, I; Lopez, C; Mendez, J; Novelli, J; Olavide, R; Parada, LM; Parejarios, J; Reyes-Marquez, R; Santoyo, S; Succar, J; Trujillo, L; Vazquez, L; Yassle, ME | 1 |
| Grinspoon, S; Herzog, D; Klibanski, A; Miller, K; Pitts, S; Thomas, L | 1 |
1 review(s) available for norethindrone and Weight Gain
| Article | Year |
|---|---|
Injectable contraception.
Topics: Abdominal Pain; Anxiety; Contraceptive Agents, Female; Dizziness; Estradiol; Female; Headache; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Safety; Weight Gain | 2007 |
12 trial(s) available for norethindrone and Weight Gain
| Article | Year |
|---|---|
Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Humans; Menstruation; Menstruation Disturbances; Norethindrone; Pilot Projects; Retrospective Studies; Uterine Hemorrhage; Weight Gain | 2019 |
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
Topics: Adult; C-Reactive Protein; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Weight Gain | 2002 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Topics: Adult; Bone Density; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Estradiol; Etidronic Acid; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lipids; Norethindrone; Prospective Studies; Time Factors; Vasomotor System; Weight Gain | 1995 |
Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Female; Headache; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norpregnenes; Patient Dropouts; Progesterone Congeners; Weight Gain | 1993 |
A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills.
Topics: Adolescent; Adult; Breast; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Prospective Studies; Uterine Hemorrhage; Weight Gain | 1993 |
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain | 1999 |
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain | 1999 |
Effect of low-dose oral contraceptives on androgenic markers and acne.
Topics: Acne Vulgaris; Adolescent; Adrenal Glands; Adult; Androgens; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovary; Sex Hormone-Binding Globulin; Testosterone; Weight Gain | 1999 |
Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mestranol; Middle Aged; Norethindrone; Pregnancy; Treatment Failure; Uterine Hemorrhage; Weight Gain | 2000 |
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage; Weight Gain | 2000 |
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa.
Topics: Adipose Tissue; Adult; Anorexia Nervosa; Body Composition; Body Mass Index; Calcium; Contraceptives, Oral, Combined; Dietary Supplements; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hydrocortisone; Norethindrone; Time Factors; Vitamins; Weight Gain | 2001 |
5 other study(ies) available for norethindrone and Weight Gain
| Article | Year |
|---|---|
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult | 2010 |
Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Endometriosis; Female; Humans; Metrorrhagia; Norethindrone; Norethindrone Acetate; Pelvic Pain; Retrospective Studies; Weight Gain; Young Adult | 2012 |
A new and practical oral contraceptive agent: norethindrone with mestranol.
Topics: Adult; Contraception; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mestranol; Norethindrone; Weight Gain | 1963 |
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |
Antiandrogenic properties of nomegestrol acetate.
Topics: Androgen Antagonists; Animals; Cyproterone Acetate; Cytosol; Dose-Response Relationship, Drug; Genitalia, Male; Male; Megestrol; Norethindrone; Norpregnadienes; Organ Size; Progesterone Congeners; Prostate; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testosterone; Weight Gain | 1995 |